A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
Category: Oncology Innovations
The new Focused Ultrasound Cancer Immunotherapy Center positions UVA Health as the worldwide leader in translational FUS immuno-oncology research.
A team of UVA Health researchers has found evidence that screening for STAT3 mutations will help to better classify and diagnose patients with LGL leukemia.
UVA Health lung cancer specialists will discuss the latest developments in lung cancer management. Bring your questions.
UVA Children's pediatric oncology researchers have developed a molecule to block a key determinant of T-ALL cell survival.
Blue light cystoscopy better pinpoints bladder cancer and improves access to life-saving surveillance after diagnosis.
Through a significant investment over 8 years, we became Virginia's first National Cancer Institute-designated comprehensive cancer center.
This groundbreaking animal-model research moves us closer to understanding why GI health plays a key role in treating breast cancer.
Find out why lymphoma and leukemia patients can mount a protective immune response to coronavirus and other findings from UVA Health experts.
With nationally known urologic oncologists and surgeons, UVA prostate cancer patients get top-level care from a ‘SEAL team’ of specialists.